Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

382
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
382
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical value of computed tomography in suspected prosthetic valve dysfunction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

The value of Continuous Remote Monitoring in Clinical Decision Making After Same-day Discharge Metabolic Bariatric Surgery.

Obesity surgery·2026
Same author

Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.

European heart journal open·2025
Same author

Response to the Comment on "Evaluation of a Predictive Model and Clinical Outcomes in Mild Acute Pancreatitis: Towards Evidence-Based Early Discharge".

Digestive diseases and sciences·2025
Same author

Evaluation of a Predictive Model and Clinical Outcomes in Mild Acute Pancreatitis: Towards Evidence-Based Early Discharge.

Digestive diseases and sciences·2025
Same author

Telepsychiatry in the emergency department: a pilot study on remote psychiatric assessment in the Netherlands.

International journal of emergency medicine·2025

相关实验视频

Updated: May 5, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.0K

恶性瘤,前血栓突变,以及静脉血栓形成的风险.

Jeanet W Blom1, Carine J M Doggen, Susanne Osanto

  • 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

JAMA
|February 11, 2005
PubMed
概括

癌症患者面临着明显更高的静脉血栓形成风险,特别是在诊断后的几个月内或有远程转移. 像Faktor V Leiden这样的基因突变进一步提高了这种风险.

科学领域:

  • 在瘤学瘤学.
  • 血液学 血液学 血液学
  • 遗传学 是一个遗传学.

背景情况:

  • 静脉血栓是癌症患者常见和严重的并发症,影响他们的生活质量.
  • 识别患有血栓形成风险较高的癌症患者对于主动管理至关重要.

研究的目的:

  • 为了评估癌症患者的血栓形成风险.
  • 评估瘤部位,转移和原血栓突变对这种风险的影响.

主要方法:

  • 一项病例控制研究 (MEGA) 涉及3220名静脉血栓症患者和2131名对照.
  • 通过调查问卷和DNA分析收集的数据用于因子V莱登和前列红蛋白20210A突变.

主要成果:

  • 癌症患者患静脉血栓的风险增加了7倍.
  • 血液,肺和胃肠道癌症构成最高的风险.
  • 在诊断后的最初几个月,患有远程转移,以及携带V因子Leiden或前列血20210A突变的携带者中,风险明显更高.

结论:

  • 癌症患者,特别是那些最近被诊断出癌症或转移的患者,有明显增加的静脉血栓形成的风险.
  • 血栓前基因突变放大了这种风险,强调了个性化风险评估的需要.

更多相关视频

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

4.5K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K

相关实验视频

Last Updated: May 5, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.0K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

4.5K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.2K